Waleed F. Khalaf, M.D., Ph.D.

Assistant Professor of Clinical

waleed.khalaf@vanderbilt.edu
Faculty Appointments
Assistant Professor of Clinical Medicine
Education
Ph.D., Microbiology & Immunology, Indiana University, Indianapolis, IndianaM.D., MEDICINE MD, Indiana University, Indianapolis, IndianaB.A., Earlham School of Religion, Richmond, Indiana
Publications
Khalaf WF, Caldwell ME, Reddy N. Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma. J Natl Compr Canc Netw. 2013 Feb 2/1/2013; 11(2): 137-40; quiz 140. PMID: 23411380, PII: 11/2/137, ISSN: 1540-1413.

Yang G, Khalaf W, van de Locht L, Jansen JH, Gao M, Thompson MA, van der Reijden BA, Gutmann DH, Delwel R, Clapp DW, Hiebert SW. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol. Cell. Biol. 2005 Jul; 25(14): 5869-79. PMID: 15988004, PMCID: PMC1168824, PII: 25/14/5869, DOI: 10.1128/MCB.25.14.5869-5879.2005, ISSN: 0270-7306.

Yang G, Khalaf W, van de Locht L, Jansen JH, van der Reijden BA, Müller-Tidow C, Delwel HR, Serve H, Clapp DW, Hiebert SW. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML. Ann. Hematol [print-electronic]. 2004 Jun; 83(6): 329-30. PMID: 15052372, DOI: 10.1007/s00277-003-0841-8, ISSN: 0939-5555.

Yang G, Khalaf W, van de Locht L, Jansen JH, van der Reijden BA, Müller-Tidow C, Delwel HR, Serve H, Clapp DW, Hiebert SW. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML. Ann. Hematol. 2004; 83 Suppl 1: S83. PMID: 15124686, DOI: 10.1007/s00277-004-0850-2, ISSN: 0939-5555.